Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya Zigler

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Plos One|September 1, 2010
CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanomaVladislava O Melnikova, Andrey S Dobroff, Maya Zigler, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2017
PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in miceYael Langut, Alaa Talhami, Samarasimhareddy Mamidi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2010
Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotypeGabriel J Villares, Maya Zigler, Andrey S Dobroff, et al.
Cancer Immunology Research|June 1, 2016
HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune MicroenvironmentMaya Zigler, Alexei Shir, Salim Joubran, et al.
Plos One|May 5, 2026
EGFR-targeted affibody-polyIC polyplex kills EGFR-overexpressing cancer cells without activating the EGFRAnne Pettikiriarachchi, Yelena Ugolev, Richard Birkinshaw, et al.
Neoplasia (New York, N.Y.)|May 14, 2008
Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitorsToshio Kuwai, Toru Nakamura, Takamitsu Sasaki, et al.
Cancer Research|September 19, 2012
Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxinRussell R Braeuer, Maya Zigler, Takafumi Kamiya, et al.
Cancer Research|November 1, 2008
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNAGabriel J Villares, Maya Zigler, Hua Wang, et al.
Cancer Research|April 7, 2011
Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progressionMaya Zigler, Gabriel J Villares, Andrey S Dobroff, et al.
The Journal of Biological Chemistry|August 26, 2009
Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasisVladislava O Melnikova, Krishnakumar Balasubramanian, Gabriel J Villares, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Plos One|September 1, 2010
CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanomaVladislava O Melnikova, Andrey S Dobroff, Maya Zigler, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2017
PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in miceYael Langut, Alaa Talhami, Samarasimhareddy Mamidi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2010
Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotypeGabriel J Villares, Maya Zigler, Andrey S Dobroff, et al.
Cancer Immunology Research|June 1, 2016
HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune MicroenvironmentMaya Zigler, Alexei Shir, Salim Joubran, et al.
Plos One|May 5, 2026
EGFR-targeted affibody-polyIC polyplex kills EGFR-overexpressing cancer cells without activating the EGFRAnne Pettikiriarachchi, Yelena Ugolev, Richard Birkinshaw, et al.
Neoplasia (New York, N.Y.)|May 14, 2008
Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitorsToshio Kuwai, Toru Nakamura, Takamitsu Sasaki, et al.
Cancer Research|September 19, 2012
Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxinRussell R Braeuer, Maya Zigler, Takafumi Kamiya, et al.
Cancer Research|November 1, 2008
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNAGabriel J Villares, Maya Zigler, Hua Wang, et al.
Cancer Research|April 7, 2011
Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progressionMaya Zigler, Gabriel J Villares, Andrey S Dobroff, et al.
The Journal of Biological Chemistry|August 26, 2009
Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasisVladislava O Melnikova, Krishnakumar Balasubramanian, Gabriel J Villares, et al.
Pageof 3